Osteoporotic Vertebral Compression Fracture Cohort Study
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age50-80
SponsorWangjing Hospital, China Academy of Chinese Medical Sciences
About this trial
The study aims to construct an early warning model for Osteoporotic Vertebral Compression Fracture (OVCF) by integrating TCM syndrome patterns with modern risk factors. This is a multi-center cohort study on OVCF integrated with disease and syndrome differentiation in Traditional Chinese Medicine (TCM).
Eligibility criteria
Qualifiers
None
Disqualifiers
Patients with serious concomitant cardiovascular/cerebrovascular diseases, liver/kidney diseases, malignant tumors, or other wasting diseases, and patients with infectious diseases.
Patients with other endocrine system diseases, such as Cushing's syndrome, hyperthyroidism, hypothyroidism, etc.
Patients who have participated in other clinical trials within the past 3 months.
Patients with concomitant Alzheimer's disease, mental illnesses or depression, or those unable to cooperate to complete the trial.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
200 Participants
are grouped into 4 trial groupsSponsors and collaborators
Wangjing Hospital, China Academy of Chinese Medical Sciences
Lead sponsor
Hunan University of Traditional Chinese Medicine
Collaborator
Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine
Collaborator
Shandong Wendeng Orthopedic Hospital
Collaborator
Source ClinicalTrials.gov